# A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

> **NCT04265261** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 139 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Placebo
- **DRUG:** RG7774

## Key facts

- **NCT ID:** NCT04265261
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-05
- **Primary completion:** 2023-07-19
- **Final completion:** 2023-07-19
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04265261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04265261, "A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04265261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*